How useful are risk scores in determining bleeding risk and antithrombotic therapy duration after primary PCI?
30 August 2024 (08:00 - 17:30)
Organised by: 
About the speaker
Mater Private Network, Dublin 7 (Ireland)
4 More presentations in this session
Professor A. Kastrati (Munich, DE)
Assistant Professor B. Stahli (Zurich, CH)
Should 12 months of dual antiplatelet therapy still be the default recommendation after primary PCI?
Professor S. James (Uppsala, SE)
Access the full session
The Event
ESC Congress 2024
30 August - 2 September 2024
